Lisinopril Hct 20/25mg: Out-of-specification Test Results
Sandoz Lisinopril HCT 20/25mg tablets are being recalled across Canada because they failed quality testing and do not meet specifications. This is a Class I recall, which means the product could cause serious health problems. The affected medication was distributed throughout Canada.
- Product
- Sandoz Lisinopril HCT 20/25mg
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2025-10-08
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/f4fce4c4-c69c-40f5-8b91-fee3a363e5d7